Detalhe da pesquisa
1.
Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events.
J Eur Acad Dermatol Venereol
; 37(5): 976-983, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652273
2.
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study.
Br J Dermatol
; 184(5): 857-870, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969489
3.
Topical therapy of atopic dermatitis with a focus on pimecrolimus.
J Eur Acad Dermatol Venereol
; 35(7): 1505-1518, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33834524
4.
A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task force.
J Eur Acad Dermatol Venereol
; 35(4): 787-796, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090558
5.
The impact of airborne pollution on atopic dermatitis: a literature review.
Br J Dermatol
; 183(1): 16-23, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31794065
6.
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr study.
Br J Dermatol
; 183(4): 664-672, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173852
7.
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.
Br J Dermatol
; 183(2): 242-255, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31995838
8.
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension.
Br J Dermatol
; 182(1): 85-96, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595499
9.
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.
Br J Dermatol
; 182(6): 1423-1429, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444799
10.
Safety and efficacy of topical, fixed-dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a phase II trial.
J Eur Acad Dermatol Venereol
; 34(5): 1098-1104, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721327
11.
Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study.
Br J Dermatol
; 180(5): 1050-1057, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30500065
12.
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.
Br J Dermatol
; 181(3): 492-504, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719709
13.
TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registries.
Br J Dermatol
; 180(4): 790-801, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761486
14.
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion.
J Eur Acad Dermatol Venereol
; 33(7): 1224-1231, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31056788
15.
Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials.
J Eur Acad Dermatol Venereol
; 32(8): 1305-1313, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29512200
16.
Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.
Osteoporos Int
; 27(12): 3615-3626, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27497815
17.
Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
Br J Dermatol
; 174(4): 770-7, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26663215
18.
Optimizing outcomes for paediatric atopic dermatitis.
Br J Dermatol
; 170 Suppl 1: 31-7, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24720616
19.
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).
Br J Dermatol
; 171(6): 1318-25, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24980543
20.
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.
J Dermatolog Treat
; 33(3): 1521-1530, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222559